skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Association of Cortical ß-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.

Journal Article · · JAMA Neurology

IMPORTANCE: ß-Amyloid deposits are a pathologic hallmark of Alzheimer disease (AD). However, the extent to which cortical ß-amyloid protein in the absence of insoluble deposits is associated with classic features of AD appear to be unknown. OBJECTIVE: To examine the associations of cortical ß-amyloid protein in the absence of insoluble deposits with cognitive decline, neurofibrillary tangles, other age-associated neuropathologic conditions, and APOE. DESIGN, SETTING, AND PARTICIPANTS: This analysis combines data from 2 community-based clinicopathologic cohort studies of aging. The Religious Orders Study started in 1994, and the Rush Memory and Aging Project started in 1997. Both studies are ongoing. Participants without known dementia were enrolled and agreed to annual clinical evaluations and brain donation after death. Primary analyses focused on individuals without ß-amyloid deposits. Data analyses occurred in mid-September 2018. MAIN OUTCOMES AND MEASURES: ß-Amyloid protein abundance was measured by targeted proteomics using selected reaction monitoring. ß-Amyloid deposits were detected using immunohistochemistry. Other neuropathologic indices were quantified via uniform structured evaluation. Linear mixed models were used to examine the association of ß-amyloid protein with cognitive decline. Regression models examined the protein associations with neuropathologic outcomes and the APOE genotype. RESULTS: By mid-September 2018, 3575 older persons were enrolled, and 1559 had died and undergone brain autopsy. Proteomic data were collected in 1208 individuals, and 5 with missing cognitive scores were excluded. Of the remaining 1203, primary analyses focused on 148 individuals (12.3%) without ß-amyloid deposits. In this group, the mean (SD) age at death was 87.0 (7.0) years, and 84 individuals (56.8%) were women. In the absence of ß-amyloid deposits, we did not observe an association of ß-amyloid protein with decline in episodic memory, but the protein was associated with faster rates of decline in processing speed (mean [SE] change, -0.014 [0.005]; P?=?.008) and visuospatial abilities (mean [SE] change, -0.013 [0.005]; P?=?.006). We did not observe protein association with paired helical filament tau tangle density. The protein was associated with amyloid angiopathy (odds ratio, 1.38 [95% CI, 1.15-1.67]; P?

Research Organization:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
OSTI ID:
1642068
Report Number(s):
PNNL-SA-147568
Journal Information:
JAMA Neurology, Vol. 76, Issue 7
Country of Publication:
United States
Language:
English

Similar Records

Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia
Journal Article · Tue Jul 03 00:00:00 EDT 2018 · Annals of Neurology · OSTI ID:1642068

Association of AK4 Protein From Stem Cell–Derived Neurons With Cognitive Reserve
Journal Article · Wed Aug 10 00:00:00 EDT 2022 · Neurology · OSTI ID:1642068

Association of small vessel disease with tau pathology
Journal Article · Wed Jan 19 00:00:00 EST 2022 · Acta Neuropathologica · OSTI ID:1642068